The Medicines and Healthcare products Regulatory Agency (MHRA) has revealed its regulatory roadmap for the development of new and robust regulations for medical devices in the UK. The plan aims to safeguard patient safety while facilitating access to innovative medical technologies for all UK patients. The UK's standing as a global leader in the field of medical technology innovation is expected to be bolstered through these measures. The regulatory framework addresses transformative technologies such as new implantable devices, healthcare AI, software, and diagnostics for early disease detection and prevention.
The MHRA plans to implement priority measures this year to ensure patient safety, with core elements of the new framework scheduled to be rolled out by 2025. Dr. Laura Squire, the med tech regulatory reform lead and chief officer for healthcare, quality, and access at MHRA, highlighted the importance of a comprehensive plan for significant improvements to the regulatory framework for medical devices in the coming years. The new framework is intended to strengthen the MHRA's ability to ensure patient safety while fostering an environment conducive to the launch of innovative healthcare products.
The regulatory roadmap also outlines collaboration with stakeholders, including patients, to gather feedback and provide early insights into the upcoming changes. Additionally, the plan introduces the AI Airlock regulatory sandbox, set to launch in April 2024. This virtual collaborative space aims to bring together expertise from regulatory organisations, government, innovators, academia, and the NHS to support the development of AI as a medical device. The AI Airlock will facilitate the generation of robust evidence for advanced technologies while ensuring their potential benefits to patient care.
Click here to read the original news story.